Global Prescription Medicine Market Research Report 2022

Report Format: PDF   |   Report ID: 5514415   |   Published Date: August 2022   |   Pages:  115  

Choose License
Market Analysis and Insights: Global Prescription Medicine Market
The global Prescription Medicine market size is projected to reach US$  million by 2028, from US$  million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Original Brand Drug accounting for % of the Prescription Medicine global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Prescription Medicine market size is valued at US$  million in 2021, while the North America and Europe Prescription Medicine are US$  million and US$  million, severally. The proportion of the North America is  % in 2021, while China and Europe are  % and respectively, and it is predicted that China proportion will reach  % in 2028, trailing a CAGR of  % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR  %,  %, and   % respectively for the next 6-year period. As for the Europe Prescription Medicine landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prescription Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prescription Medicine market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prescription Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prescription Medicine market.
Global Prescription Medicine Scope and Market Size
Prescription Medicine market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Prescription Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Original Brand Drug
    Generic Drug
Segment by Application
    Hospital
    Clinic
    Online
    Others
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Pfizer
    Roche
    Novartis
    Johnson & Johnson
    Merck & Co.
    Sanofi
    AbbVie
    GlaxoSmithKline
    Amgen
    Gilead Science
    Bristol-Myers Squibb
    AstraZeneca
    Eli Lilly
    Bayer
    Novo Nordisk
    Takeda
    Boehringer-Ingelheim
    Allergan
    Teva Pharmaceutical Industries
    Mylan
    Astellas Pharma
    Biogen
    CSL
    Daiichi Sankyo
    Otsuka Holdings
    UCB
    LES LABORATOIRES SERVIER
    Bausch Health Companies
    Eisai
    Abbott Laboratories
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prescription Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Original Brand Drug
        1.2.3 Generic Drug
    1.3 Market by Application
        1.3.1 Global Prescription Medicine Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Online
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Prescription Medicine Market Perspective (2017-2028)
    2.2 Prescription Medicine Growth Trends by Region
        2.2.1 Prescription Medicine Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Prescription Medicine Historic Market Size by Region (2017-2022)
        2.2.3 Prescription Medicine Forecasted Market Size by Region (2023-2028)
    2.3 Prescription Medicine Market Dynamics
        2.3.1 Prescription Medicine Industry Trends
        2.3.2 Prescription Medicine Market Drivers
        2.3.3 Prescription Medicine Market Challenges
        2.3.4 Prescription Medicine Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Prescription Medicine Players by Revenue
        3.1.1 Global Top Prescription Medicine Players by Revenue (2017-2022)
        3.1.2 Global Prescription Medicine Revenue Market Share by Players (2017-2022)
    3.2 Global Prescription Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Prescription Medicine Revenue
    3.4 Global Prescription Medicine Market Concentration Ratio
        3.4.1 Global Prescription Medicine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prescription Medicine Revenue in 2021
    3.5 Prescription Medicine Key Players Head office and Area Served
    3.6 Key Players Prescription Medicine Product Solution and Service
    3.7 Date of Enter into Prescription Medicine Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Prescription Medicine Breakdown Data by Type
    4.1 Global Prescription Medicine Historic Market Size by Type (2017-2022)
    4.2 Global Prescription Medicine Forecasted Market Size by Type (2023-2028)
5 Prescription Medicine Breakdown Data by Application
    5.1 Global Prescription Medicine Historic Market Size by Application (2017-2022)
    5.2 Global Prescription Medicine Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Prescription Medicine Market Size (2017-2028)
    6.2 North America Prescription Medicine Market Size by Country (2017-2022)
    6.3 North America Prescription Medicine Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Prescription Medicine Market Size (2017-2028)
    7.2 Europe Prescription Medicine Market Size by Country (2017-2022)
    7.3 Europe Prescription Medicine Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Prescription Medicine Market Size (2017-2028)
    8.2 Asia-Pacific Prescription Medicine Market Size by Country (2017-2022)
    8.3 Asia-Pacific Prescription Medicine Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Prescription Medicine Market Size (2017-2028)
    9.2 Latin America Prescription Medicine Market Size by Country (2017-2022)
    9.3 Latin America Prescription Medicine Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Prescription Medicine Market Size (2017-2028)
    10.2 Middle East & Africa Prescription Medicine Market Size by Country (2017-2022)
    10.3 Middle East & Africa Prescription Medicine Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Prescription Medicine Introduction
        11.1.4 Pfizer Revenue in Prescription Medicine Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Roche
        11.2.1 Roche Company Detail
        11.2.2 Roche Business Overview
        11.2.3 Roche Prescription Medicine Introduction
        11.2.4 Roche Revenue in Prescription Medicine Business (2017-2022)
        11.2.5 Roche Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Prescription Medicine Introduction
        11.3.4 Novartis Revenue in Prescription Medicine Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Detail
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Prescription Medicine Introduction
        11.4.4 Johnson & Johnson Revenue in Prescription Medicine Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Merck & Co.
        11.5.1 Merck & Co. Company Detail
        11.5.2 Merck & Co. Business Overview
        11.5.3 Merck & Co. Prescription Medicine Introduction
        11.5.4 Merck & Co. Revenue in Prescription Medicine Business (2017-2022)
        11.5.5 Merck & Co. Recent Development
    11.6 Sanofi
        11.6.1 Sanofi Company Detail
        11.6.2 Sanofi Business Overview
        11.6.3 Sanofi Prescription Medicine Introduction
        11.6.4 Sanofi Revenue in Prescription Medicine Business (2017-2022)
        11.6.5 Sanofi Recent Development
    11.7 AbbVie
        11.7.1 AbbVie Company Detail
        11.7.2 AbbVie Business Overview
        11.7.3 AbbVie Prescription Medicine Introduction
        11.7.4 AbbVie Revenue in Prescription Medicine Business (2017-2022)
        11.7.5 AbbVie Recent Development
    11.8 GlaxoSmithKline
        11.8.1 GlaxoSmithKline Company Detail
        11.8.2 GlaxoSmithKline Business Overview
        11.8.3 GlaxoSmithKline Prescription Medicine Introduction
        11.8.4 GlaxoSmithKline Revenue in Prescription Medicine Business (2017-2022)
        11.8.5 GlaxoSmithKline Recent Development
    11.9 Amgen
        11.9.1 Amgen Company Detail
        11.9.2 Amgen Business Overview
        11.9.3 Amgen Prescription Medicine Introduction
        11.9.4 Amgen Revenue in Prescription Medicine Business (2017-2022)
        11.9.5 Amgen Recent Development
    11.10 Gilead Science
        11.10.1 Gilead Science Company Detail
        11.10.2 Gilead Science Business Overview
        11.10.3 Gilead Science Prescription Medicine Introduction
        11.10.4 Gilead Science Revenue in Prescription Medicine Business (2017-2022)
        11.10.5 Gilead Science Recent Development
    11.11 Bristol-Myers Squibb
        11.11.1 Bristol-Myers Squibb Company Detail
        11.11.2 Bristol-Myers Squibb Business Overview
        11.11.3 Bristol-Myers Squibb Prescription Medicine Introduction
        11.11.4 Bristol-Myers Squibb Revenue in Prescription Medicine Business (2017-2022)
        11.11.5 Bristol-Myers Squibb Recent Development
    11.12 AstraZeneca
        11.12.1 AstraZeneca Company Detail
        11.12.2 AstraZeneca Business Overview
        11.12.3 AstraZeneca Prescription Medicine Introduction
        11.12.4 AstraZeneca Revenue in Prescription Medicine Business (2017-2022)
        11.12.5 AstraZeneca Recent Development
    11.13 Eli Lilly
        11.13.1 Eli Lilly Company Detail
        11.13.2 Eli Lilly Business Overview
        11.13.3 Eli Lilly Prescription Medicine Introduction
        11.13.4 Eli Lilly Revenue in Prescription Medicine Business (2017-2022)
        11.13.5 Eli Lilly Recent Development
    11.14 Bayer
        11.14.1 Bayer Company Detail
        11.14.2 Bayer Business Overview
        11.14.3 Bayer Prescription Medicine Introduction
        11.14.4 Bayer Revenue in Prescription Medicine Business (2017-2022)
        11.14.5 Bayer Recent Development
    11.15 Novo Nordisk
        11.15.1 Novo Nordisk Company Detail
        11.15.2 Novo Nordisk Business Overview
        11.15.3 Novo Nordisk Prescription Medicine Introduction
        11.15.4 Novo Nordisk Revenue in Prescription Medicine Business (2017-2022)
        11.15.5 Novo Nordisk Recent Development
    11.16 Takeda
        11.16.1 Takeda Company Detail
        11.16.2 Takeda Business Overview
        11.16.3 Takeda Prescription Medicine Introduction
        11.16.4 Takeda Revenue in Prescription Medicine Business (2017-2022)
        11.16.5 Takeda Recent Development
    11.17 Boehringer-Ingelheim
        11.17.1 Boehringer-Ingelheim Company Detail
        11.17.2 Boehringer-Ingelheim Business Overview
        11.17.3 Boehringer-Ingelheim Prescription Medicine Introduction
        11.17.4 Boehringer-Ingelheim Revenue in Prescription Medicine Business (2017-2022)
        11.17.5 Boehringer-Ingelheim Recent Development
    11.18 Allergan
        11.18.1 Allergan Company Detail
        11.18.2 Allergan Business Overview
        11.18.3 Allergan Prescription Medicine Introduction
        11.18.4 Allergan Revenue in Prescription Medicine Business (2017-2022)
        11.18.5 Allergan Recent Development
    11.19 Teva Pharmaceutical Industries
        11.19.1 Teva Pharmaceutical Industries Company Detail
        11.19.2 Teva Pharmaceutical Industries Business Overview
        11.19.3 Teva Pharmaceutical Industries Prescription Medicine Introduction
        11.19.4 Teva Pharmaceutical Industries Revenue in Prescription Medicine Business (2017-2022)
        11.19.5 Teva Pharmaceutical Industries Recent Development
    11.20 Mylan
        11.20.1 Mylan Company Detail
        11.20.2 Mylan Business Overview
        11.20.3 Mylan Prescription Medicine Introduction
        11.20.4 Mylan Revenue in Prescription Medicine Business (2017-2022)
        11.20.5 Mylan Recent Development
    11.21 Astellas Pharma
        11.21.1 Astellas Pharma Company Detail
        11.21.2 Astellas Pharma Business Overview
        11.21.3 Astellas Pharma Prescription Medicine Introduction
        11.21.4 Astellas Pharma Revenue in Prescription Medicine Business (2017-2022)
        11.21.5 Astellas Pharma Recent Development
    11.22 Biogen
        11.22.1 Biogen Company Detail
        11.22.2 Biogen Business Overview
        11.22.3 Biogen Prescription Medicine Introduction
        11.22.4 Biogen Revenue in Prescription Medicine Business (2017-2022)
        11.22.5 Biogen Recent Development
    11.23 CSL
        11.23.1 CSL Company Detail
        11.23.2 CSL Business Overview
        11.23.3 CSL Prescription Medicine Introduction
        11.23.4 CSL Revenue in Prescription Medicine Business (2017-2022)
        11.23.5 CSL Recent Development
    11.24 Daiichi Sankyo
        11.24.1 Daiichi Sankyo Company Detail
        11.24.2 Daiichi Sankyo Business Overview
        11.24.3 Daiichi Sankyo Prescription Medicine Introduction
        11.24.4 Daiichi Sankyo Revenue in Prescription Medicine Business (2017-2022)
        11.24.5 Daiichi Sankyo Recent Development
    11.25 Otsuka Holdings
        11.25.1 Otsuka Holdings Company Detail
        11.25.2 Otsuka Holdings Business Overview
        11.25.3 Otsuka Holdings Prescription Medicine Introduction
        11.25.4 Otsuka Holdings Revenue in Prescription Medicine Business (2017-2022)
        11.25.5 Otsuka Holdings Recent Development
    11.26 UCB
        11.26.1 UCB Company Detail
        11.26.2 UCB Business Overview
        11.26.3 UCB Prescription Medicine Introduction
        11.26.4 UCB Revenue in Prescription Medicine Business (2017-2022)
        11.26.5 UCB Recent Development
    11.27 LES LABORATOIRES SERVIER
        11.27.1 LES LABORATOIRES SERVIER Company Detail
        11.27.2 LES LABORATOIRES SERVIER Business Overview
        11.27.3 LES LABORATOIRES SERVIER Prescription Medicine Introduction
        11.27.4 LES LABORATOIRES SERVIER Revenue in Prescription Medicine Business (2017-2022)
        11.27.5 LES LABORATOIRES SERVIER Recent Development
    11.28 Bausch Health Companies
        11.28.1 Bausch Health Companies Company Detail
        11.28.2 Bausch Health Companies Business Overview
        11.28.3 Bausch Health Companies Prescription Medicine Introduction
        11.28.4 Bausch Health Companies Revenue in Prescription Medicine Business (2017-2022)
        11.28.5 Bausch Health Companies Recent Development
    11.29 Eisai
        11.29.1 Eisai Company Detail
        11.29.2 Eisai Business Overview
        11.29.3 Eisai Prescription Medicine Introduction
        11.29.4 Eisai Revenue in Prescription Medicine Business (2017-2022)
        11.29.5 Eisai Recent Development
    11.30 Abbott Laboratories
        11.30.1 Abbott Laboratories Company Detail
        11.30.2 Abbott Laboratories Business Overview
        11.30.3 Abbott Laboratories Prescription Medicine Introduction
        11.30.4 Abbott Laboratories Revenue in Prescription Medicine Business (2017-2022)
        11.30.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Prescription Medicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Original Brand Drug Table 3. Key Players of Generic Drug Table 4. Global Prescription Medicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Prescription Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Prescription Medicine Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Prescription Medicine Market Share by Region (2017-2022) Table 8. Global Prescription Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Prescription Medicine Market Share by Region (2023-2028) Table 10. Prescription Medicine Market Trends Table 11. Prescription Medicine Market Drivers Table 12. Prescription Medicine Market Challenges Table 13. Prescription Medicine Market Restraints Table 14. Global Prescription Medicine Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Prescription Medicine Market Share by Players (2017-2022) Table 16. Global Top Prescription Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Medicine as of 2021) Table 17. Ranking of Global Top Prescription Medicine Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Prescription Medicine Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Prescription Medicine Product Solution and Service Table 21. Date of Enter into Prescription Medicine Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Prescription Medicine Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Prescription Medicine Revenue Market Share by Type (2017-2022) Table 25. Global Prescription Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Prescription Medicine Revenue Market Share by Type (2023-2028) Table 27. Global Prescription Medicine Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Prescription Medicine Revenue Market Share by Application (2017-2022) Table 29. Global Prescription Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Prescription Medicine Revenue Market Share by Application (2023-2028) Table 31. North America Prescription Medicine Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Prescription Medicine Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Prescription Medicine Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Prescription Medicine Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Prescription Medicine Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Prescription Medicine Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Prescription Medicine Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Prescription Medicine Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Prescription Medicine Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Prescription Medicine Market Size by Country (2023-2028) & (US$ Million) Table 41. Pfizer Company Detail Table 42. Pfizer Business Overview Table 43. Pfizer Prescription Medicine Product Table 44. Pfizer Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 45. Pfizer Recent Development Table 46. Roche Company Detail Table 47. Roche Business Overview Table 48. Roche Prescription Medicine Product Table 49. Roche Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 50. Roche Recent Development Table 51. Novartis Company Detail Table 52. Novartis Business Overview Table 53. Novartis Prescription Medicine Product Table 54. Novartis Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 55. Novartis Recent Development Table 56. Johnson & Johnson Company Detail Table 57. Johnson & Johnson Business Overview Table 58. Johnson & Johnson Prescription Medicine Product Table 59. Johnson & Johnson Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 60. Johnson & Johnson Recent Development Table 61. Merck & Co. Company Detail Table 62. Merck & Co. Business Overview Table 63. Merck & Co. Prescription Medicine Product Table 64. Merck & Co. Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 65. Merck & Co. Recent Development Table 66. Sanofi Company Detail Table 67. Sanofi Business Overview Table 68. Sanofi Prescription Medicine Product Table 69. Sanofi Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 70. Sanofi Recent Development Table 71. AbbVie Company Detail Table 72. AbbVie Business Overview Table 73. AbbVie Prescription Medicine Product Table 74. AbbVie Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 75. AbbVie Recent Development Table 76. GlaxoSmithKline Company Detail Table 77. GlaxoSmithKline Business Overview Table 78. GlaxoSmithKline Prescription Medicine Product Table 79. GlaxoSmithKline Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 80. GlaxoSmithKline Recent Development Table 81. Amgen Company Detail Table 82. Amgen Business Overview Table 83. Amgen Prescription Medicine Product Table 84. Amgen Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 85. Amgen Recent Development Table 86. Gilead Science Company Detail Table 87. Gilead Science Business Overview Table 88. Gilead Science Prescription Medicine Product Table 89. Gilead Science Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 90. Gilead Science Recent Development Table 91. Bristol-Myers Squibb Company Detail Table 92. Bristol-Myers Squibb Business Overview Table 93. Bristol-Myers Squibb Prescription MedicineProduct Table 94. Bristol-Myers Squibb Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 95. Bristol-Myers Squibb Recent Development Table 96. AstraZeneca Company Detail Table 97. AstraZeneca Business Overview Table 98. AstraZeneca Prescription MedicineProduct Table 99. AstraZeneca Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 100. AstraZeneca Recent Development Table 101. Eli Lilly Company Detail Table 102. Eli Lilly Business Overview Table 103. Eli Lilly Prescription MedicineProduct Table 104. Eli Lilly Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 105. Eli Lilly Recent Development Table 106. Bayer Company Detail Table 107. Bayer Business Overview Table 108. Bayer Prescription MedicineProduct Table 109. Bayer Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 110. Bayer Recent Development Table 111. Novo Nordisk Company Detail Table 112. Novo Nordisk Business Overview Table 113. Novo Nordisk Prescription MedicineProduct Table 114. Novo Nordisk Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 115. Novo Nordisk Recent Development Table 116. Takeda Company Detail Table 117. Takeda Business Overview Table 118. Takeda Prescription MedicineProduct Table 119. Takeda Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 120. Takeda Recent Development Table 121. Boehringer-Ingelheim Company Detail Table 122. Boehringer-Ingelheim Business Overview Table 123. Boehringer-Ingelheim Prescription MedicineProduct Table 124. Boehringer-Ingelheim Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 125. Boehringer-Ingelheim Recent Development Table 126. Allergan Company Detail Table 127. Allergan Business Overview Table 128. Allergan Prescription MedicineProduct Table 129. Allergan Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 130. Allergan Recent Development Table 131. Teva Pharmaceutical Industries Company Detail Table 132. Teva Pharmaceutical Industries Business Overview Table 133. Teva Pharmaceutical Industries Prescription MedicineProduct Table 134. Teva Pharmaceutical Industries Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 135. Teva Pharmaceutical Industries Recent Development Table 136. Mylan Company Detail Table 137. Mylan Business Overview Table 138. Mylan Prescription MedicineProduct Table 139. Mylan Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 140. Mylan Recent Development Table 141. Astellas Pharma Company Detail Table 142. Astellas Pharma Business Overview Table 143. Astellas Pharma Prescription MedicineProduct Table 144. Astellas Pharma Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 145. Astellas Pharma Recent Development Table 146. Biogen Company Detail Table 147. Biogen Business Overview Table 148. Biogen Prescription MedicineProduct Table 149. Biogen Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 150. Biogen Recent Development Table 151. CSL Company Detail Table 152. CSL Business Overview Table 153. CSL Prescription MedicineProduct Table 154. CSL Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 155. CSL Recent Development Table 156. Daiichi Sankyo Company Detail Table 157. Daiichi Sankyo Business Overview Table 158. Daiichi Sankyo Prescription MedicineProduct Table 159. Daiichi Sankyo Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 160. Daiichi Sankyo Recent Development Table 161. Otsuka Holdings Company Detail Table 162. Otsuka Holdings Business Overview Table 163. Otsuka Holdings Prescription MedicineProduct Table 164. Otsuka Holdings Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 165. Otsuka Holdings Recent Development Table 166. UCB Company Detail Table 167. UCB Business Overview Table 168. UCB Prescription MedicineProduct Table 169. UCB Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 170. UCB Recent Development Table 171. LES LABORATOIRES SERVIER Company Detail Table 172. LES LABORATOIRES SERVIER Business Overview Table 173. LES LABORATOIRES SERVIER Prescription MedicineProduct Table 174. LES LABORATOIRES SERVIER Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 175. LES LABORATOIRES SERVIER Recent Development Table 176. Bausch Health Companies Company Detail Table 177. Bausch Health Companies Business Overview Table 178. Bausch Health Companies Prescription MedicineProduct Table 179. Bausch Health Companies Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 180. Bausch Health Companies Recent Development Table 181. Eisai Company Detail Table 182. Eisai Business Overview Table 183. Eisai Prescription MedicineProduct Table 184. Eisai Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 185. Eisai Recent Development Table 186. Abbott Laboratories Company Detail Table 187. Abbott Laboratories Business Overview Table 188. Abbott Laboratories Prescription MedicineProduct Table 189. Abbott Laboratories Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 190. Abbott Laboratories Recent Development Table 191. Research Programs/Design for This Report Table 192. Key Data Information from Secondary Sources Table 193. Key Data Information from Primary Sources List of Figures Figure 1. Global Prescription Medicine Market Share by Type: 2021 VS 2028 Figure 2. Original Brand Drug Features Figure 3. Generic Drug Features Figure 4. Global Prescription Medicine Market Share by Application in 2021 & 2028 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Online Case Studies Figure 8. Others Case Studies Figure 9. Prescription Medicine Report Years Considered Figure 10. Global Prescription Medicine Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Prescription Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Prescription Medicine Market Share by Region: 2021 VS 2028 Figure 13. Global Prescription Medicine Market Share by Players in 2021 Figure 14. Global Top Prescription Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Medicine as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Prescription Medicine Revenue in 2021 Figure 16. North America Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Prescription Medicine Market Share by Country (2017-2028) Figure 18. United States Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Prescription Medicine Market Share by Country (2017-2028) Figure 22. Germany Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Prescription Medicine Market Share by Region (2017-2028) Figure 30. China Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Prescription Medicine Market Share by Country (2017-2028) Figure 38. Mexico Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Prescription Medicine Market Share by Country (2017-2028) Figure 42. Turkey Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Pfizer Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 45. Roche Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 46. Novartis Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 47. Johnson & Johnson Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 48. Merck & Co. Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 49. Sanofi Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 50. AbbVie Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 51. GlaxoSmithKline Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 52. Amgen Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 53. Gilead Science Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 55. AstraZeneca Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 56. Eli Lilly Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 57. Bayer Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 58. Novo Nordisk Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 59. Takeda Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 60. Boehringer-Ingelheim Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 61. Allergan Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 62. Teva Pharmaceutical Industries Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 63. Mylan Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 64. Astellas Pharma Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 65. Biogen Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 66. CSL Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 67. Daiichi Sankyo Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 68. Otsuka Holdings Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 69. UCB Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 70. LES LABORATOIRES SERVIER Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 71. Bausch Health Companies Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 72. Eisai Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 73. Abbott Laboratories Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us